Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Struthers

Showing results (1-10 of 306) with videos related to

Pageof 31
Sort By:
Journal of Cardiac Failure|March 1, 1996
Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failureA D Struthers
Postgraduate Medical Journal|July 1, 1985
The choice of antihypertensive therapy in the diabetic patientA D Struthers
BMJ (Clinical Research Ed.)|June 18, 1994
Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?A D Struthers
Current Opinion in Cardiology|July 1, 1994
Health care delivery for chronic congestive heart failure in the United KingdomA D Struthers
European Heart Journal|November 1, 1996
Diastolic dysfunction and ANP/BNP levelsA D Struthers
Heart (British Cardiac Society)|December 13, 2005
Angiotensin blockade or aldosterone blockade as the third neuroendocrine-blocking drug in mild but symptomatic heart failure patientsA D Struthers
European Heart Journal|July 10, 1999
Further defining the role for natriuretic peptide levels in clinical practiceA D Struthers
European Heart Journal|December 24, 1997
Rationalizing the heart failure trials: from theory to practiceA D Struthers
British Heart Journal|December 1, 1994
Effect of ACE inhibitors on the atrial natriuretic peptides in heart failureA D Struthers
Heart (British Cardiac Society)|April 16, 2005
Pathophysiology of heart failure following myocardial infarctionA D Struthers
Pageof 31

Showing results (1-10 of 306) with videos related to

Sort By:
Pageof 31
Journal of Cardiac Failure|March 1, 1996
Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failureA D Struthers
Postgraduate Medical Journal|July 1, 1985
The choice of antihypertensive therapy in the diabetic patientA D Struthers
BMJ (Clinical Research Ed.)|June 18, 1994
Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?A D Struthers
Current Opinion in Cardiology|July 1, 1994
Health care delivery for chronic congestive heart failure in the United KingdomA D Struthers
European Heart Journal|November 1, 1996
Diastolic dysfunction and ANP/BNP levelsA D Struthers
Heart (British Cardiac Society)|December 13, 2005
Angiotensin blockade or aldosterone blockade as the third neuroendocrine-blocking drug in mild but symptomatic heart failure patientsA D Struthers
European Heart Journal|July 10, 1999
Further defining the role for natriuretic peptide levels in clinical practiceA D Struthers
European Heart Journal|December 24, 1997
Rationalizing the heart failure trials: from theory to practiceA D Struthers
British Heart Journal|December 1, 1994
Effect of ACE inhibitors on the atrial natriuretic peptides in heart failureA D Struthers
Heart (British Cardiac Society)|April 16, 2005
Pathophysiology of heart failure following myocardial infarctionA D Struthers
Pageof 31